• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza-Omics and the Host Response: Recent Advances and Future Prospects

tetano

Editor, Senior Moderator
Pathogens. 2017 Jun 10;6(2). pii: E25. doi: 10.3390/pathogens6020025.
[h=1]Influenza-Omics and the Host Response: Recent Advances and Future Prospects.[/h] Powell JD[SUP]1[/SUP], Waters KM[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza A viruses (IAV) continually evolve and have the capacity to cause global pandemics. Because IAV represents an ongoing threat, identifying novel therapies and host innate immune factors that contribute to IAV pathogenesis is of considerable interest. This review summarizes the relevant literature as it relates to global host responses to influenza infection at both the proteome and transcriptome level. The various-omics infection systems that include but are not limited to ferrets, mice, pigs, and even the controlled infection of humans are reviewed. Discussion focuses on recent advances, remaining challenges, and knowledge gaps as it relates to influenza-omics infection outcomes.


[h=4]KEYWORDS:[/h] influenza; proteomics; transcriptomics

PMID: 28604586 DOI: 10.3390/pathogens6020025
Free full text
 
Back
Top Bottom